{"id":936574,"date":"2026-02-12T08:35:37","date_gmt":"2026-02-12T13:35:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/"},"modified":"2026-02-12T08:35:37","modified_gmt":"2026-02-12T13:35:37","slug":"cormedix-to-participate-in-upcoming-investor-conferences-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/","title":{"rendered":"CorMedix to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BERKELEY HEIGHTS, N.J., Feb.  12, 2026  (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in March.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\">\n            <strong>Leerink Partners Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:20%;width:20%;min-width:20%\">Date:<\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:79%;width:79%;min-width:79%\">March 10, 2026<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>\u00a0<\/td>\n<td>1:00pm Eastern<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>\u00a0<\/td>\n<td>Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\u00a0<\/td>\n<td>\n            <a href=\"https:\/\/event.summitcast.com\/view\/mT9poctHDNthc6b89WqVjf\/Esw43qxHhjEay25zQ5HBQk\" rel=\"nofollow\" target=\"_blank\">Link to webcast<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\">\n            <strong>Citizens Life Sciences Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Date:<\/td>\n<td>\u00a0<\/td>\n<td>March 11, 2026<\/td>\n<\/tr>\n<tr>\n<td>Time:<\/td>\n<td>\u00a0<\/td>\n<td>9:35am Eastern<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>\u00a0<\/td>\n<td>Fireside Chat<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\u00a0<\/td>\n<td>\n            <a href=\"https:\/\/event.summitcast.com\/view\/BuMiPNPtyHKimMF6k4AFMd\/RnWCuBXCXMP459Y8DJek9K\" rel=\"nofollow\" target=\"_blank\">Link to webcast<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\">\n            <strong>Barclays 28<\/strong><br \/>\n            <sup><br \/>\n              <strong>th <\/strong><br \/>\n            <\/sup><br \/>\n            <strong>Annual Global Healthcare Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td>Date:<\/td>\n<td>\u00a0<\/td>\n<td>March 12, 2026<\/td>\n<\/tr>\n<tr>\n<td>Format:<\/td>\n<td>\u00a0<\/td>\n<td>One-on-one investor meetings<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About CorMedix<br \/><\/strong>CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing <em>DefenCath<\/em><sup>\u00ae<\/sup> (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, CorMedix is also commercializing a portfolio of anti-infective products, including <em>MINOCIN<\/em><sup>\u00ae<\/sup> (minocycline) for Injection, <em>REZZAYO<\/em><sup>\u00ae<\/sup> (rezafungin for injection), <em>VABOMERE<\/em><sup>\u00ae<\/sup> (meropenem and vaborbactam), <em>ORBACTIV<\/em>\u2122 (oritavancin), <em>BAXDELA<\/em><sup>\u00ae<\/sup> (delafloxacin), and <em>KIMYRSA<\/em><sup>\u00ae<\/sup> (oritavancin), as well as <em>TOPROL-XL<\/em><sup>\u00ae<\/sup> (metoprolol succinate).<\/p>\n<p align=\"justify\">CorMedix has ongoing clinical studies for <em>DefenCath<\/em> in Total Parenteral Nutrition (TPN) and Pediatric Hemodialysis populations and also intends to develop <em>DefenCath<\/em> as a catheter lock solution for use in other patient populations. <em>REZZAYO<\/em> is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT. Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PzwPfIzC-lXDaOOMpb1xuFSkuABLCE-Ivzbl1N4T7R1W2IWesMSDvR1YSxlqqxZ0k8y8LZWnom-_kvw6YaCZIMEIB7XyuNASsEDuEHc6ygRYWqjfBqIUPwhgWXNy6Ip4naBdqUMKo5FcZkJxk38rnUD_1_j6i_e2UkQoZI0RmuX8QAWQZELl0YQJCseYNDBI9HIq-4Yr_3c2V6yu1TW7nO4txwxHSN762eGz8S6YuS8=\" rel=\"nofollow\" target=\"_blank\">www.cormedix.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=484a7YbQH2eoBqBJLVfj9IkRg5wUrUdFUR8DXLcXr7znFdqUS2yshFbKkVKoj7DJ9uXV63VCR_ucFROL-7rMQQ==\" rel=\"nofollow\" target=\"_blank\">www.melinta.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>Managing Director<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HFH-ee2dPbNdXghdJMAjv6UPoycMEZYFGK_WaDp0M08HVUv7U_izHSGFJ1PquodYQwUOWoRWOpjjyDVAbl94tzDdRBG8FybhFl5_Hvpc4rU_3acrvegavAx1s7x5Hxrp\" rel=\"nofollow\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><br \/>(617) 430-7576<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGU4NWFiOTYtNjdmNC00NTE0LWFkZDgtN2JjZjFkMDk0NDg2LTUwMDA2NTY3OC0yMDI2LTAyLTEyLWVu\/tiny\/CorMedix-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERKELEY HEIGHTS, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in March. Leerink Partners Global Healthcare Conference Date: \u00a0 March 10, 2026 Time: \u00a0 1:00pm Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Citizens Life Sciences Conference Date: \u00a0 March 11, 2026 Time: \u00a0 9:35am Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Barclays 28 th Annual Global Healthcare Conference Date: \u00a0 March 12, 2026 Format: \u00a0 One-on-one investor meetings \u00a0 \u00a0 \u00a0 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CorMedix to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936574","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERKELEY HEIGHTS, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in March. Leerink Partners Global Healthcare Conference Date: \u00a0 March 10, 2026 Time: \u00a0 1:00pm Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Citizens Life Sciences Conference Date: \u00a0 March 11, 2026 Time: \u00a0 9:35am Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Barclays 28 th Annual Global Healthcare Conference Date: \u00a0 March 12, 2026 Format: \u00a0 One-on-one investor meetings \u00a0 \u00a0 \u00a0 &hellip; Continue reading &quot;CorMedix to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T13:35:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CorMedix to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-02-12T13:35:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/\",\"name\":\"CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\",\"datePublished\":\"2026-02-12T13:35:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-to-participate-in-upcoming-investor-conferences-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CorMedix to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/","og_locale":"en_US","og_type":"article","og_title":"CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"BERKELEY HEIGHTS, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that senior management will be presenting and participating in investor meetings at upcoming investor conferences taking place in March. Leerink Partners Global Healthcare Conference Date: \u00a0 March 10, 2026 Time: \u00a0 1:00pm Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Citizens Life Sciences Conference Date: \u00a0 March 11, 2026 Time: \u00a0 9:35am Eastern Format: \u00a0 Fireside Chat Webcast: \u00a0 Link to webcast \u00a0 \u00a0 \u00a0 Barclays 28 th Annual Global Healthcare Conference Date: \u00a0 March 12, 2026 Format: \u00a0 One-on-one investor meetings \u00a0 \u00a0 \u00a0 &hellip; Continue reading \"CorMedix to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-12T13:35:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CorMedix to Participate in Upcoming Investor Conferences","datePublished":"2026-02-12T13:35:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/","name":"CorMedix to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==","datePublished":"2026-02-12T13:35:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MzQwNyM3NDIyNTYyIzUwMDA2NTY3OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-to-participate-in-upcoming-investor-conferences-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CorMedix to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936574"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936574\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}